Skip to content

RPRX

Royalty Pharma plc

Revenue to net income

Key figures

MetricLast 12 months5-year CAGR
Revenue$2.6B+2.3%
Operating income$1.5B−0.5%
Net income$672M−4.6%
EPS$1.53+6.2%